Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution — FDA Drug Shortage

To Be Discontinued — Vantive US Healthcare LLC

The FDA lists a drug shortage record for Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution (solution) from Vantive US Healthcare LLC with status To Be Discontinued. The shortage was first posted on Aug 3, 2026.

Shortage details

Status
To Be Discontinued
Company
Vantive US Healthcare LLC
Package NDC
0941-0415-07
Dosage Form
Solution
Presentation
DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0415-07)
Initial Posting
Aug 3, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.